GA
CNTA
General Atlantic’s Centessa Pharmaceuticals CNTA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $127M | Hold |
9,681,818
| – | – | 3.51% | 8 |
|
|
2025
Q1 | $139M | Hold |
9,681,818
| – | – | 4.67% | 6 |
|
|
2024
Q4 | $162M | Hold |
9,681,818
| – | – | 5.77% | 5 |
|
|
2024
Q3 | $155M | Hold |
9,681,818
| – | – | 4.4% | 6 |
|
|
2024
Q2 | $87.4M | Hold |
9,681,818
| – | – | 2.75% | 9 |
|
|
2024
Q1 | $109M | Hold |
9,681,818
| – | – | 2.54% | 10 |
|
|
2023
Q4 | $77.1M | Hold |
9,681,818
| – | – | 1.11% | 11 |
|
|
2023
Q3 | $62.6M | Hold |
9,681,818
| – | – | 0.97% | 17 |
|
|
2023
Q2 | $59.9M | Hold |
9,681,818
| – | – | 0.94% | 16 |
|
|
2023
Q1 | $37.3M | Hold |
9,681,818
| – | – | 0.43% | 21 |
|
|
2022
Q4 | $30M | Hold |
9,681,818
| – | – | 0.4% | 22 |
|
|
2022
Q3 | $38.9M | Hold |
9,681,818
| – | – | 0.46% | 19 |
|
|
2022
Q2 | $47.2M | Hold |
9,681,818
| – | – | 0.62% | 18 |
|
|
2022
Q1 | $86.8M | Hold |
9,681,818
| – | – | 0.79% | 12 |
|
|
2021
Q4 | $109M | Hold |
9,681,818
| – | – | 0.84% | 14 |
|
|
2021
Q3 | $162M | Buy |
9,681,818
+8,181,818
| +545% | +$137M | 0.95% | 12 |
|
|
2021
Q2 | $33.3M | Buy |
+1,500,000
| New | +$33.3M | 0.24% | 14 |
|